Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 2
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Nobivac KC - V/NRP/02/1487 Intervet International B.V., Nīderlande QI07AF dogs Vairāk

Medicinal product information

Pharmaceutical form: nasal drops, lyophilisate and solvent for suspension
International name (active substance): Live Bordetella bronchiseptica,Live Canine parainfluenza virus (CPi) strain Cornell
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 18-Aug-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1487-01 5 Stikla flakons, 1 deva [PDF] [PDF] [PDF]
V/NRP/02/1487-04 25 Stikla flakons, 1 deva -
Ficoxil 57 mg V/DCP/21/0047 Industrial Veterinaria, S.A., Spānija QM01AH90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Firocoxib
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-May-2026)
Labelling text: [PDF] Zāļu_informācija_ZA_M_LI (13-May-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-May-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0047-01 57 mg 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/21/0047-02 57 mg 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/21/0047-03 57 mg 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/21/0047-04 57 mg 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/21/0047-05 57 mg 18 PVDH/PE/PVH/Al blisteris, 10 tablete -
Ficoxil 227 mg V/DCP/21/0048 Industrial Veterinaria, S.A., Spānija QM01AH90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Firocoxib
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-May-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-May-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-May-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0048-01 227 mg 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/21/0048-02 227 mg 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/21/0048-03 227 mg 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/21/0048-04 227 mg 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/21/0048-05 227 mg 18 PVDH/PE/PVH/Al blisteris, 10 tablete -
Robexera 5 mg V/DCP/23/0027 KRKA, d.d., Novo mesto, Slovēnija QM01AH91 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Robenacoxib
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija;KRKA-Farma d.o.o., Horvātija
Date of authorisation/renewal: 27-Jun-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-May-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-May-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-May-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0027-01 1 OPA/Al/PVH-Al blisteris, 10 tablete -
V/DCP/23/0027-02 3 OPA/Al/PVH-Al blisteris, 10 tablete -
V/DCP/23/0027-03 6 OPA/Al/PVH-Al blisteris, 10 tablete -
Robexera 10 mg V/DCP/23/0028 KRKA, d.d., Novo mesto, Slovēnija QM01AH91 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Robenacoxib
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija;KRKA-Farma d.o.o., Horvātija
Date of authorisation/renewal: 27-Jun-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-May-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-May-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-May-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0028-01 1 OPA/Al/PVH-Al blisteris, 10 tablete -
V/DCP/23/0028-02 3 OPA/Al/PVH-Al blisteris, 10 tablete -
V/DCP/23/0028-03 6 OPA/Al/PVH-Al blisteris, 10 tablete -
Robexera 20 mg V/DCP/23/0029 KRKA, d.d., Novo mesto, Slovēnija QM01AH91 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Robenacoxib
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija;KRKA-Farma d.o.o., Horvātija
Date of authorisation/renewal: 27-Jun-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-May-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-May-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-May-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0029-01 1 OPA/Al/PVH-Al blisteris, 10 tablete -
V/DCP/23/0029-02 3 OPA/Al/PVH-Al blisteris, 10 tablete -
V/DCP/23/0029-03 6 OPA/Al/PVH-Al blisteris, 10 tablete -
Robexera 40 mg V/DCP/23/0030 KRKA, d.d., Novo mesto, Slovēnija QM01AH91 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Robenacoxib
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija;KRKA-Farma d.o.o., Horvātija
Date of authorisation/renewal: 27-Jun-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-May-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-May-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-May-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0030-01 1 OPA/Al/PVH-Al blisteris, 10 tablete -
V/DCP/23/0030-02 3 OPA/Al/PVH-Al blisteris, 10 tablete -
V/DCP/23/0030-03 6 OPA/Al/PVH-Al blisteris, 10 tablete -
PROPALIN 50 mg/ml V/MRP/05/1639 Vetoquinol S.A., Francija QG04BX91 dogs Vairāk

Medicinal product information

Pharmaceutical form: syrup
International name (active substance): Phenylpropanolamine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol S.A., Francija
Date of authorisation/renewal: 29-Dec-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-May-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/05/1639-01 40 mg/ml 1 ABPE pudele, 30 ml -
V/MRP/05/1639-02 40 mg/ml 1 ABPE pudele, 100 ml -
Avishield IB H120 - V/DCP/18/0002 Izo S.r.l., Itālija QI01AD07 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for oculonasal suspension/use in drinking water
International name (active substance): Attenuated live virus of avian infectious bronchitis, Massachusetts serotype, strain H-120
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release GENERA Inc., Horvātija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (25-May-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (25-May-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (25-May-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0002-01 10 Stikla flakons, 1000 deva -
V/DCP/18/0002-02 10 Stikla flakons, 2500 deva -
V/DCP/18/0002-03 10 Stikla flakons, 5000 deva -
Avishield IB GI-13 - V/DCP/20/0014 Izo S.r.l., Itālija QI01AD07 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for oculonasal suspension/use in drinking water
International name (active substance): Live avian infectious bronchitis virus, variant strain V-173/11
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release GENERA Inc., Horvātija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (25-May-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (25-May-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (25-May-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0014-01 10 Stikla flakons, 1000 deva -
V/DCP/20/0014-02 10 Stikla flakons, 2500 deva -
V/DCP/20/0014-03 10 Stikla flakons, 5000 deva -
Cobactan 2,5% 25 mg/ml V/NRP/05/1275 Intervet International B.V., Nīderlande QJ01DE90 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Cefquinome (as cefquinome sulfate)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International GmbH, Vācija;Aprilia Animal Health S.r.l., Itālija
Date of authorisation/renewal: 15-Oct-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/05/1275-01 25 mg/ml 1 Stikla flakons, 50 ml -
V/NRP/05/1275-02 25 mg/ml 1 Stikla flakons, 100 ml -
Bovilis Bovipast RSP - V/NRP/05/1660 Intervet International B.V., Nīderlande QI02AL04 cattle Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated bovine respiratory sincitial (BRS) virus, strain EV908, Inactivated parainfluenza-3 virus, str. SF-4 Reisinger, Inactivated Mannheimia (Pasteurella) haemolytica A1, strain M4/1
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 08-Jun-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Feb-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Feb-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (26-Mar-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/05/1660-01 1 Stikla flakons, 50 ml -
Bovilis Rotavec Corona - V/MRP/08/0002 Intervet International B.V., Nīderlande QI02AL01 cattle Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Bovine coronavirus, strain Mebus, Inactivated, Bovine rotavirus, strain UK-Compton, Inactivated, E. coli F5 (K99) adhesin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 09-Jul-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Jul-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Jul-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/08/0002-01 10 Stikla flakons, 2 ml -
V/MRP/08/0002-02 1 Stikla flakons, 10 ml -
V/MRP/08/0002-03 1 Stikla flakons, 40 ml -
V/MRP/08/0002-04 1 Stikla flakons, 100 ml -
V/MRP/08/0002-05 1 PET flakons, 10 ml -
V/MRP/08/0002-06 1 PET flakons, 40 ml -
V/MRP/08/0002-07 1 PET flakons, 100 ml -
Clorexivet 4% 40 mg/ml V/DCP/26/0021 NEXTMUNE ITALY S.R.L., Itālija QD08AC02 dogs Vairāk

Medicinal product information

Pharmaceutical form: shampoo
International name (active substance): Chlorhexidine digluconate solution
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Floris Veterinaire Producten B.V., Nīderlande
Date of authorisation/renewal: 14-Apr-2026
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (14-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (14-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (14-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/26/0021-01 1 ABPE pudele, 250 ml -
Pimocard 1.25 mg V/MRP/15/0060 Eurovet Animal Health B.V., Nīderlande QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: flavoured tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Eurovet Animal Health B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 31-Jul-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jun-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jun-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Jun-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/15/0060-01 1,25 mg 2 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0060-02 1,25 mg 5 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0060-03 1,25 mg 10 PVH/PE/PVAc blisters, 10 tablete [JPG]
V/MRP/15/0060-04 1,25 mg 25 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0060-05 1,25 mg 2 Al/Al blisteris, 10 tablete -
V/MRP/15/0060-06 1,25 mg 5 Al/Al blisteris, 10 tablete -
V/MRP/15/0060-07 1,25 mg 10 Al/Al blisteris, 10 tablete [JPG]
V/MRP/15/0060-08 1,25 mg 25 Al/Al blisteris, 10 tablete -
Pimocard 2.5 mg V/MRP/15/0061 Eurovet Animal Health B.V., Nīderlande QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: flavoured tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 31-Jul-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jun-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jun-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Jun-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/15/0061-01 2,5 mg 2 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0061-02 2,5 mg 5 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0061-03 2,5 mg 10 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0061-04 2,5 mg 25 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0061-05 2,5 mg 2 Al/Al blisteris, 10 tablete -
V/MRP/15/0061-06 2,5 mg 5 Al/Al blisteris, 10 tablete -
V/MRP/15/0061-07 2,5 mg 10 Al/Al blisteris, 10 tablete -
V/MRP/15/0061-08 2,5 mg 25 Al/Al blisteris, 10 tablete -
Pimocard 10 mg V/MRP/15/0063 Eurovet Animal Health B.V., Nīderlande QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: flavoured tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Eurovet Animal Health B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 31-Jul-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jun-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jun-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Jun-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/15/0063-01 10 mg 2 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0063-02 10 mg 5 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0063-03 10 mg 10 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0063-04 10 mg 25 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0063-05 10 mg 4 Al/Al blisteris, 5 tablete -
V/MRP/15/0063-06 10 mg 10 Al/Al blisteris, 5 tablete -
V/MRP/15/0063-07 10 mg 20 Al/Al blisteris, 5 tablete -
V/MRP/15/0063-08 10 mg 50 Al/Al blisteris, 5 tablete -
Pimocard 5 mg V/MRP/15/0062 Eurovet Animal Health B.V., Nīderlande QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: flavoured tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Eurovet Animal Health B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 31-Jul-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jun-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jun-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Jun-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/15/0062-01 5 mg 2 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0062-02 5 mg 5 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0062-03 5 mg 10 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0062-04 5 mg 25 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0062-05 5 mg 4 Al/Al blisteris, 5 tablete -
V/MRP/15/0062-06 5 mg 10 Al/Al blisteris, 5 tablete -
V/MRP/15/0062-07 5 mg 20 Al/Al blisteris, 5 tablete -
V/MRP/15/0062-08 5 mg 50 Al/Al blisteris, 5 tablete -
Metaphosol 200 mg/ml V/NRP/14/0035 Alivira Animal Health Limited;, Īrija QA12CX90 cattle; pigs; sheep; goats; horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Toldimfos sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release LABORATORIOS KARIZOO, S.A., Spānija
Date of authorisation/renewal: 02-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-May-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/14/0035-01 200 mg/ml 1 Stikla (tumša) flakons, 50 ml -
V/NRP/14/0035-02 200 mg/ml 1 Stikla (tumša) flakons, 100 ml -
V/NRP/14/0035-03 200 mg/ml 10 Stikla (tumša) flakons, 50 ml -
V/NRP/14/0035-04 200 mg/ml 12 Stikla (tumša) flakons, 100 ml -
ERYSIN SINGLE SHOT - V/NRP/00/1059 Bioveta, a.s., Čehija QI09AB03 pigs Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Erysipelothrix rhusiopathiae
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 09-Mar-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-May-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-May-2026)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (22-May-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/00/1059-01 1 Stikla flakons, 100 ml -
V/NRP/00/1059-02 5 Stikla flakons, 20 ml -
V/NRP/00/1059-03 1 Plastikāta flakons, 100 ml -

3081 record

© Food and veterinary service · 2026 Cookies policy